Skip to main content
SpringerLink
Log in

Does Hemopoietic Stem Cell Transplantation Have a Role in Treatment of Severe Rheumatoid Arthritis?

  • Published:
Journal of Clinical Immunology Aims and scope Submit manuscript

Abstract

Based on animal models and limited clinical experience, there is considerable interest in use of high-dose immunosuppression followed by hemopoietic stem cell transplantation as treatment for severe rheumatoid arthritis. Because of its relatively low treatment-related mortality and morbidity, autologous transplantation is a more attractive option than allogeneic transplantation for initial clinical trials, even though anecdotal reports suggest that allogeneic transplantation has a greater likelihood of bringing about long-term disease control. The approach remains experimental with many unanswered questions such as the value and safety of high-dose therapy without transplantation, the need for T cell purging, the possible deleterious effects of post-transplant hemopoietic growth factors and the potential of “mini” allogeneic transplantation (a process whereby intense immunosuppression is combined with less intense myelosuppression). To achieve quick progress it is essential that clinical trials be carefully designed with all cases being reported to the Autoimmune Disease Stem Cell Project Database.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. Wulffraat N, van Royen A, Bierings M, Vossen J, Kuis W: Autologous haemopoietic stem-cell transplantation in four patients with refractory juvenile chronic arthritis. Lancet 353:550-553, 1999

    Google Scholar 

  2. Mant MJ, Russell AS, Percy JS, Davis P, Messner HA: Immunosuppression as initial treatment for gold induced aplastic anemia. J Rheumatol 14:1026-1029, 1987

    Google Scholar 

  3. Cooley HM, Snowden JA, Grigg AP, Wicks IP: Outcome of rheumatoid arthritis and psoriasis following autologous stem cell transplantation for hematologic malignancy. Arthritis Rheum 40: 1712-1715, 1997

    Google Scholar 

  4. Takeuchi K, Inaba M, Miyashima S, Ogawa R, Ikehara S: A new strategy for treatment of autoimmune diseases in chimeric resistant MRL/lpr mice. Blood 91:4616-4623, 1998

    Google Scholar 

  5. Knaan-Shanzer S, Houben P, Kinwel-Bohré EPM, van Bekkum DW: Remission induction of adjuvant arthritis in rats by total body irradiation and autologous bone marrow transplantation. Bone Marrow Transplant 8:333-338, 1991

    Google Scholar 

  6. Wolfe F, Mitchell DM, Sibley JT, Fries JF, Bloch DA, Williams CA, Spitz PW, Haga M, Kleinheksel SM, Cathey MA: The mortality of rheumatoid arthritis. Arthritis Rheumatism 37:481-494, 1994

    Google Scholar 

  7. Myllykangas-Luosujarvi RA, Aho K, Isomaki HA: Mortality in rheumatoid arthritis. Semin Arthritis Rheum 25:193-202, 1995

    Google Scholar 

  8. Scott DL, Symmons DP, Coulton BL, Popert AJ: Longterm outcome of treating rheumatoid arthritis: Results after 20 years. Lancet 1:1108-1111, 1987

    Google Scholar 

  9. Felson DT, Anderson JJ, Meenan RF: The comparative efficacy and toxicity of second-line drugs in rheumatoid arthritis: Results of two metaanalyses. Arthritis Rheumatism 33:1449-1461, 1990

    Google Scholar 

  10. Symmons DP: Mortality in rheumatoid arthritis. Br J Rheumatol 27(Suppl 1):44-54, 1988

    Google Scholar 

  11. Clarke AE, Zowall H, Levinton C, Assimakopoulos H, Sibley JT, Haga M, Shiroky J, Neville C, Lubeck DP, Grover SA, Esdaile JM: Direct and indirect medical costs incurred by Canadian patients with rheumatoid arthritis: A 12 year study. J Rheumatol 24:1051-1060, 1997

    Google Scholar 

  12. McIntosh E: The cost of rheumatoid arthritis. Br J Rheumatol 35:781-790, 1996

    Google Scholar 

  13. Pincus T: The underestimated long term medical and economic consequences of rheumatoid arthritis. Drugs 50(Suppl 1):1-14, 1995

    Google Scholar 

  14. Atkinson K, Nivison-Smith K, Hawkins T: Haemopoietic stem cell transplantation in Australia, 1992–1995: A report from the Australian Bone Marrow Transplant Registry. Aust NZ J Med 27:408-419, 1997

    Google Scholar 

  15. Snowden JA, Nivison-Smith I, Biggs JC, Brooks PM: Risk taking in patients with rheumatoid arthritis: Are the risks of haemopoietic stem cell transplantation acceptable? Rheumatology (Oxford) 38: 321-324, 1999

    Google Scholar 

  16. Baldwin JL, Storb R, Thomas ED, Mannik M: Bone marrow transplantation in patients with gold-induced marrow aplasia. Arthritis Rheum 20:1043-1048, 1977

    Google Scholar 

  17. Jacobs P, Vincent MD, Martell RW: Prolonged remission of severe refractory rheumatoid arthritis following allogeneic bone marrow transplantation for drug-induced aplastic anaemia. Bone Marrow Transplant 1:237-239, 1986

    Google Scholar 

  18. Lowenthal RM, Cohen ML, Atkinson K, Biggs JC: Apparent cure of rheumatoid arthritis by bone marrow transplantation. J Rheumatol 20:137-140, 1993

    Google Scholar 

  19. Snowden JA, Kearney P, Kearney A, Cooley HM, Grigg A, Jacobs P, Bergman J, Brooks PM, Biggs JC: Long-term outcome of autoimmune disease following allogeneic bone marrow transplantation. Arthritis Rheum 41:453-459, 1998

    Google Scholar 

  20. Nelson JL, Torrez R, Louie FM, Choe OS, Storb R, Sullivan KM: Pre-existing autoimmune disease in patients with longterm survival after allogeneic bone marrow transplantation. J Rheumatol 24(Suppl 48):23-29, 1997

    Google Scholar 

  21. McKendry RJ, Huebsch L, Leclair B: Progression of rheumatoid arthritis following bone marrow transplantation. A case report with a 13-year followup. Arthritis Rheum 39:1246-1253, 1996

    Google Scholar 

  22. Euler HH, Marmont AM, Bacigalupo A, Fastenrath S, Dreger P, Hoffknecht M, Zander AR, Schalke B, Hahn U, Haas R, Schmitz N: Early recurrence or persistence of autoimmune diseases after unmanipulated autologous stem cell transplantation. Blood 88: 3621-3625, 1996

    Google Scholar 

  23. Joske DJ, Ma DTS, Langlands DR, Owen ET: Autologous bonemarrow transplantation for rheumatoid arthritis. Lancet 350:337-338, 1997

    Google Scholar 

  24. Burt RK, Traynor AE, Pope R, Schroeder J, Cohen B, Karlin KH, Lobeck L, Goolsby C, Rowlings P, Davis FA, Stefoski D, Terry C, Keever-Taylor C, Rosen S, Vesole D, Fishman M, Brush M, Mujias S, Villa M, Burns WH: Treatment of autoimmune disease by intense immunosuppressive conditioning and autologous hematopoietic stem cell transplantation. Blood 92:3505-3514, 1998

    Google Scholar 

  25. Durez P, Toungouz M, Schandené L, Lambermont M, Goldman M: Remission and immune reconstitution after T-cell-depleted stem-cell transplantation for rheumatoid arthritis [letter]. Lancet 352:881, 1998

    Google Scholar 

  26. Lowenthal RM, Sullivan SA, Parker N, Marsden KA: G-CSF-primed bone marrow cells for autologous transplantation. Lancet 347:1125, 1996

    Google Scholar 

  27. Lowenthal RM, Tuck D, Tegg E, Marsden KA, Rees B, Luck J, Ragg S, Parker N, Kotlovsky N: Hemopoietic stem cell harvesting and transplantation using G-CSF-primed bone marrow: comparison with unprimed bone marrow and G-CSF-primed peripheral blood stem cells. Cytotherapy 1:409-416, 1999

    Google Scholar 

  28. Tyndall A, Millikan S: Bone marrow transplantation. Baillière's Clinical Rheumatology 13:719-735, 1999

    Google Scholar 

  29. Gabriel SE, Crowson CS, Luthra HS, Wagner JL, O'Fallon WM: Modeling the lifetime costs of rheumatoid arthritis. J Rheumatol 26:1269-1274, 1999

    Google Scholar 

  30. Burt RK: Immune ablation and hematopoietic stem cell rescue for severe autoimmune diseases (SADS). Cancer Treat Res 77:317-332, 1997

    Google Scholar 

  31. Brodsky RA, Petri M, Smith BD, Seifter EJ, Spivak JL, Styler M, Dang CV, Brodsky I, Jones RJ: Immunoablative high-dose cyclophosphamide without stem-cell rescue for refractory, severe autoimmune disease. Ann Intern Med 129:1031-1035, 1998

    Google Scholar 

  32. Marmont AM: Stem cell transplantation for severe autoimmune disorders, with special reference to rheumatic diseases. J Rheumatol 24(Suppl 48):13-18, 1997

    Google Scholar 

  33. Giralt S, Estey E, Albitar M, van Besian K, Rondón G, Anderlini P, O'Brien S, Khouri I, Gajewski J, Mehra R, Claxton D, Andersson B, Beran M, Przepiorka D, Koller C, Kornblau S, Körbling M, Keating M, Kantarjian H, Champlin R: Engraftment of allogeneic hematopoietic progenitor cells with purine analogcontaining chemotherapy: Harnessing graft-versus-leukemia without myeloablative therapy. Blood 89:4531-4536, 1997

    Google Scholar 

  34. Lowenthal RM, Fabères C, Marit G, Boiron JM, Cony-Makhoul P, Pigneux A, Agape P, Vezon G, Bouzgarou R, Dazey B, Fizet D, Bernard P, Lacombe F, Reiffers J: Factors influencing haemopoietic recovery following chemotherapy-mobilised autologous peripheral blood progenitor cell transplantation for haematological malignancies: a retrospective analysis of a 10-year single institution experience. Bone Marrow Transplant 22:763-770, 1998

    Google Scholar 

  35. Snowden JA, Biggs JC, Milliken ST, Fuller A, Staniforth D, Passuello F, Renwick J, Brooks PM: A randomised, blinded, placebo-controlled, dose escalation study of the tolerability and efficacy of filgrastim for haemopoietic stem cell mobilisation in patients with severe active rheumatoid arthritis. Bone Marrow Transplant 22:1035-1041, 1998

    Google Scholar 

  36. Champlin R, Khouri I, Kornblau S, Molldrem J, Giralt S: Reinventing bone marrow transplantation: Reducing toxicity using nonmyeloablative, preparative regimens and induction of graftversus-malignancy. Current Opinion in Oncology 11:87-95, 1999

    Google Scholar 

  37. Schmitz N, Linch DC, Dreger P, Goldstone AH, Boogaerts MA, Ferrant A, Demuynck HMS, Link H, Zander A, Barge A, Borkett K: Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients. Lancet 347:353-357, 1996

    Google Scholar 

  38. Smith TJ, Hillner BE, Schmitz N, Linch DC, Dreger P, Goldstone AH, Boogaerts MA, Ferrant A, Link H, Zander A, Yanovich S, Kitchin R, Erder MH: Economic analysis of a randomized clinical trial to compare filgrastim-mobilized peripheral-blood progenitorcell transplantation and autologous bone marrow transplantation in patients with Hodgkin's and non-Hodgkin's lymphoma. J Clin Oncol 15:5-10, 1997

    Google Scholar 

  39. Snowden JA, Nink V, Cooley M, Zaunders J, Keir M, Wright L, Milliken ST, Brooks PM, Biggs JC: Composition and function of peripheral blood stem and progenitor cell harvests from patients with severe active rheumatoid arthritis. Br J Haematol 103:601-609, 1998

    Google Scholar 

  40. Ringden O, Remberger M, Runde V, Bornhauser M, Blau IW, Basara N, Holig K, Beelen DW, Hagglund H, Basu O, Ehninger G, Fauser AA: Peripheral blood stem cell transplantation from unrelated donors: A comparison with marrow transplantation. Blood 94:455-464, 1999

    Google Scholar 

  41. Brodsky RA, Smith BD: Bone marrow transplantation for autoimmune diseases. Current Opinion in Oncology 11:83-86, 1999

    Google Scholar 

  42. Gratwohl A, Tyndall A: Hematopoietic stem cell transplantations in treatment of autoimmune diseases [in German]. Zeitschrift der Rheumatologie 56:173-177, 1997

    Google Scholar 

  43. Tyndall A, Gratwohl A: Blood and marrow stem cell transplants in auto-immune disease: A consensus report written on behalf of the European League against Rheumatism (EULAR) and the European Group for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplantation 19:643-645, 1997

    Google Scholar 

  44. Munro R, Madhok R: T-cell-depleted stem-cell transplantation for rheumatoid arthritis. Lancet 352:1628-1629, 1998

    Google Scholar 

  45. Gribben JG, Linch DC, Singer CRJ, McMillan AK, Jarret M, Goldstone AH: Successful treatment of refractory Hodgkin's disease by high-dose combination chemotherapy and autologous bone marrow transplantation. Blood 73:340-344, 1989

    Google Scholar 

  46. Durez P, Toungouz M, Kentos A, Appelboom T, Goldman M: T-cell-depleted stem-cell transplantation for rheumatoid arthritis. Lancet 352:1628-1629, 1998

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Haematology/Oncology, Royal Hobart Hospital, GPO Box 10611, Hobart, Tasmania, 7001, Australia

    Raymond M. Lowenthal & Stewart R. Graham

Authors
  1. Raymond M. Lowenthal
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Stewart R. Graham
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lowenthal, R.M., Graham, S.R. Does Hemopoietic Stem Cell Transplantation Have a Role in Treatment of Severe Rheumatoid Arthritis?. J Clin Immunol 20, 17–23 (2000). https://doi.org/10.1023/A:1006634309251

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1006634309251

Search

Navigation